HIV-1 infection and low steady state viral loads

Bulletin of Mathematical Biology

Volumn 64, Issue 1, 2002, Pages 29-64

  Callaway, Duncan S ^a   Perelson, Alan S ^b  

^a Department of Obstetrics Gynecology   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ARTICLE; CELL DEATH; CELL DENSITY; CONTROLLED STUDY; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR DYNAMICS; MOLECULAR MODEL; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036381110     PISSN: 00928240     EISSN: None     Source Type: Journal    
DOI: 10.1006/bulm.2001.0266     Document Type: Article

References (56)

1. Human immunodeficiency virus drug therapy and virus load
2. Phenotype switching and disease progression in HIV-1 infection
3. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
4. Re-emergence of HIV after stopping therapy
5. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
6. Towards a general function describing T cell proliferation
7. Target cell limited and immune control models of HIV infection: A comparison
8. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
9. Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
10. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
11. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
12. Persistence of HIV-1 transcription in peripheralblood mononuclear cells in patients receiving potent antiretroviral therapy
13. The role of mononuclear phagocytes in HTLV-III/LAV infection
14. Quantitative image analysis of HIV-1 infection in lymphoid tissue
15. A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults
16. Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy
17. Influence of follicular dendritic cells on HIV dynamics
18. Dissociation of HIV-1 from follicular dendritic cells during HAART: Mathematical analysis
19. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
20. Density-dependent decay in HIV dynamics after HAART
21. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
22. Drug concentration heterogeneity facilitates the evolution of drug resistance
23. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
24. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
25. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
26. Lamivudine in children with human immunodeficiency virus infection: A phase I/II study
27. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen
28. Using viral dynamics to document the greater antiviral potency of a regimen containing Lopinavir/Ritonavir, Efavirenz, Tenofovir, and Lamivudine relative to standard HAART
29. In vivo estimates of division and death rates of human T lymphocytes
30. Improved estimates for HIV-1 clearance rate and intracellular delay
31. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques
32. HIV-1 replication in patients with undetectable plasma virus receiving HAART
33. Population dynamics of immune responses to persistent viruses
34. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
35. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection
36. Decay characteristics of HIV-1-infected compartments during combination therapy
37. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
38. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus
39. Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages
40. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
41. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
42. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen
43. Physiology of male reproduction: The testes, epididymis, and ductus deferens
44. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
45. Latency and viral persistence in HIV-1 infection
46. Persistence of infectious HIV on follicular dendritic cells
47. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
48. Portals of entry-uncovering HIV-1 nuclear transport pathways
49. Cellular and viral determinants that regulate HIV-1 infection in macrophages
50. Viral dynamics in human immunodeficiency virus type 1 infection
51. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
52. Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection
53. Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus
54. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy